Orthofix Medical Inc.
Orthofix Medical Inc. (OFIX) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
ofix · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Orthofix Medical Inc. (OFIX) measures how much investors pay for each dollar of the company's trailing earnings. OFIX's current PE ratio of N/A is calculated by dividing its stock price of $10.18 by its TTM earnings per share of -$1.48.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 8 fiscal years · Front-end computedMinQ1 · 25%79.1x
MedianQ3 · 75%329.0x
Max
At N/A, OFIX's current P/E is lower than in 0% of its annual fiscal year readings over the past 8 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Orthofix Medical Inc.You OFIX | $411M | N/A | — | -$1.48 |
 Absci Corporation ABSI | $1.0B | N/A | — | -$0.84 |
 Avanos Medical, Inc. AVNS | $1.2B | N/A | — | -$1.46 |
 Butterfly Network, Inc. BFLY | $1.2B | N/A | — | -$0.31 |
 DarioHealth Corp. DRIO | $55M | N/A | — | -$0.84 |
 Esperion Therapeutics, Inc. ESPR | $655M | N/A | — | -$0.11 |
 Standard BioTools Inc. LAB | $331M | N/A | — | -$0.20 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-2.31 | — | |
2024-12-31 FY2024 | — | $-3.30 | — | |
2023-12-31 FY2023 | — | $-4.12 | — | |
2022-12-31 FY2022 | — | $-0.98 | — | |
2021-12-31 FY2021 | — | $-1.95 | — | |
2020-12-31 FY2020 | 329.02x | $0.13 | — | |
2019-12-31 FY2019 | — | $-1.51 | — | |
2018-12-31 FY2018 | 70.29x | $0.75 | -55.9% | |
2017-12-31 FY2017 | 159.25x | $0.34 | -25.9% | |
2016-12-31 FY2016 | 214.81x | $0.17 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Orthofix Medical Inc. (OFIX) measures how much investors pay for each dollar of the company's trailing earnings. OFIX's current PE ratio of N/A is calculated by dividing its stock price of $10.18 by its TTM earnings per share of -$1.48.
Frequently asked questions
OFIX pe ratio · 6 questionsOFIX's current PE ratio is N/A as of 2026-06-08, based on a stock price of $10.18 and TTM EPS of -$1.48. Data sourced from Financial Modeling Prep via OFIX's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Orthofix Medical Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08